SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* EDELMAN JOSEPH (Last) (First) (Middle) C/O FIRST NEW YORK SECURITIES 850 THIRD AVENUE, 8TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol MIRAVANT MEDICAL TECHNOLOGIES [ MRVT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 05/04/2004
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value(1)	05/04/2004		J		4,667	A	(6)	2,783,007	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/05/2004		P		27,100	A	$3.08	2,810,107	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/12/2004		P		9,000	A	$2.6	2,819,107	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/19/2004		P		22,500	A	$1.95	2,841,607	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/21/2004		P		19,400	A	$1.99	2,861,007	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/25/2004		P		16,650	A	$2.14	2,877,657	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/26/2004		P		117,000	A	$2.93	2,994,657	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/26/2004		S		18,000	D	$2.86	2,976,657	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/27/2004		P		54,700	A	$2.98	3,031,357	I	Through Master Fund(2)
Common Stock, $0.01 par value	06/03/2004		S		106,500	D	$1.9809	2,924,857	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/12/2004		P		5,000	A	$2.51	5,000	D(3)
Common Stock, $0.01 par value	05/19/2004		P		5,000	A	$1.85	10,000	D(3)
Common Stock, $0.01 par value	06/01/2004		S		2,000	D	$2.9	8,000	D(3)
Common Stock, $0.01 par value	06/02/2004		S		2,134	D	$2.2	5,866	D(3)
Common Stock, $0.01 par value	05/14/2004		P		12,000	A	$2.59	12,000	D(4)
Common Stock, $0.01 par value	05/18/2004		P		7,000	A	$2.33	19,000	D(4)
Common Stock, $0.01 par value	05/28/2004		P		8,370	A	$2.97	3,039,727	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/28/2004		P		18,000	A	$2.93	3,057,727	I	Through Master Fund(2)
Common Stock, $0.01 par value	06/01/2004		S		6,750	D	$2.79	3,050,977	I	Through Master Fund(2)
Common Stock, $0.01 par value	05/05/2004		P		1,900	A	$3.08	59,260	I	Through FNYT(5)
Common Stock, $0.01 par value	05/12/2004		P		1,000	A	$2.6	60,260	I	Through FNYT(5)
Common Stock, $0.01 par value	05/19/2004		P		2,500	A	$1.95	62,760	I	Through FNYT(5)
Common Stock, $0.01 par value	05/21/2004		P		2,100	A	$1.99	64,860	I	Through FNYT(5)
Common Stock, $0.01 par value	05/25/2004		P		1,850	A	$2.14	66,710	I	Through FNYT(5)
Common Stock, $0.01 par value	05/26/2004		P		13,000	A	$2.93	79,710	I	Through FNYT(5)
Common Stock, $0.01 par value	05/26/2004		S		2,000	D	$2.86	77,710	I	Through FNYT(5)
Common Stock, $0.01 par value	05/27/2004		P		6,000	A	$2.98	83,710	I	Through FNYT(5)
Common Stock, $0.01 par value	05/28/2004		P		930	A	$2.97	84,640	I	Through FNYT(5)
Common Stock, $0.01 par value	05/28/2004		P		2,000	A	$2.93	86,640	I	Through FNYT(5)
Common Stock, $0.01 par value	06/01/2004		S		750	D	$2.79	85,890	I	Through FNYT(5)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* EDELMAN JOSEPH (Last) (First) (Middle) C/O FIRST NEW YORK SECURITIES 850 THIRD AVENUE, 8TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Last) (First) (Middle) 5437 CONNECTICUT AVE NW STE 100 (Street) WASHINGTON DC 20015 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* PERCEPTIVE ADVISORS LLC (Last) (First) (Middle) PERCEPTIVE CAPITAL 5437 CONNECTICUT AVENUE NW STE 100 (Street) WASHINGTON DC 20015 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Chachkes Larry (Last) (First) (Middle) C/O PERCEPTIVE ADVISORS LLC 5437 CONNECTICUT AVENUE, NW (Street) WASHINGTON DC 20015 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Williams Kevin (Last) (First) (Middle) C/O PERCEPTIVE ADVISORS LLC 5437 CONNECTICUT AVENUE, NW (Street) WASHINGTON DC 20015 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. This Form 4 is being filed by Joseph Edelman, Perceptive Life Sciences Master Fund Ltd. ("Master Fund"), Perceptive Advisors LLC ("Advisors"), Kevin Williams and Larry Chachkes. Because the SEC's electronic filing system does not allow for the disclosure of more than 30 transactions on one Form 4, the Reporting Persons are filing 2 simultaneous Form 4s to report their reportable transactions, both of which together shall be deemed a single report filed on this date. This is the 1st Form 4 of the 2 filings.

2. These securities are held by Master Fund of which Advisors is the investment advisor. Mr. Edelman is the managing member of Advisors. In accordance with Instruction 4(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund is reported herein. Each of Mr. Edelman, Advisors, Mr. Chachkes and Mr. Williams disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), beneficial ownership of any of such securities or with respect to such transactions, as applicable, except to the extent of its/his indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, Advisors, Mr. Chachkes or Mr. Williams is the beneficial owner of such securities or with respect to such transactions, as applicable, for purposes of Section 16 or for any other purposes.

3. These securities are held by Mr. Chachkes. None of the Master Fund, Advisors, Mr. Edelman or Mr. Williams has any pecuniary interest in such securities.

4. These securities are held by Mr. Williams. None of the Master Fund, Advisors, Mr. Edelman or Mr. Chachkes has any pecuniary interest in such securities.

5. These securities are held in an account of First New York Trading, LLC ("FNYT"). In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held through the FNYT account is reported herein. Mr. Edelman, Advisors, Mr. Williams and Mr. Chachkes each disclaims, for purposes of Section 16 of the Exchange Act, any beneficial ownership of any of such securities or with respect to such transactions, as applicable, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, Advisors, Mr. Williams or Mr. Chachkes is the beneficial owner of any of such securities or with respect to such transactions, as applicable, for purposes of Section 16 or for any other purposes.

6. Represents an interest payment by the Issuer to the Master Fund with respect to convertible debentures of the Issuer held by the Master Fund.

	/s/ Joseph Edelman	06/08/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.